Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
2(17%)
Results Posted
38%(3 trials)

Phase Distribution

Ph phase_1
1
8%
Ph not_applicable
11
92%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
1(8.3%)
N/ANon-phased studies
11(91.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

12

all time

Status Distribution
Active(3)
Completed(8)
Other(1)

Detailed Status

Completed8
Active, not recruiting1
Not yet recruiting1
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
2
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (8.3%)
N/A11 (91.7%)

Trials by Status

active_not_recruiting18%
completed867%
not_yet_recruiting18%
unknown18%
recruiting18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
DEVICE
Total Trials
12